Mesoblast

NEW YORK and MELBOURNE, July 13-14, 2026 Mesoblast Limited announced that it has achieved its target of treating at...

New York, USA & Melbourne, Australia, July 1, 2026 Mesoblast Limited announced that the U.S. Food and Drug Administration...

NEW YORK, USA & MELBOURNE, Australia, April 28–29, 2026 Mesoblast Limited has announced that it has achieved the patient...